1 results
More Patients Show Reduced Agitation/aggression with Rivastigmine Transdermal Monotherapy Than with Oral Monotherapies for Alzheimer’s Disease – Results From the Exept Study in Portugal.
-
- Journal:
- European Psychiatry / Volume 30 / Issue S1 / March 2015
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation